rs81204
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000218.3(KCNQ1):c.1732+43T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.23 in 1,598,214 control chromosomes in the GnomAD database, including 43,008 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 3606 hom., cov: 33)
Exomes 𝑓: 0.23 ( 39402 hom. )
Consequence
KCNQ1
NM_000218.3 intron
NM_000218.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.37
Publications
14 publications found
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
KCNQ1 Gene-Disease associations (from GenCC):
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 1Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Jervell and Lange-Nielsen syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- atrial fibrillation, familial, 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- short QT syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
- short QT syndrome type 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Jervell and Lange-Nielsen syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 11-2777075-T-C is Benign according to our data. Variant chr11-2777075-T-C is described in ClinVar as Benign. ClinVar VariationId is 1291253.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.247 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNQ1 | NM_000218.3 | c.1732+43T>C | intron_variant | Intron 14 of 15 | ENST00000155840.12 | NP_000209.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNQ1 | ENST00000155840.12 | c.1732+43T>C | intron_variant | Intron 14 of 15 | 1 | NM_000218.3 | ENSP00000155840.2 |
Frequencies
GnomAD3 genomes AF: 0.212 AC: 32248AN: 151962Hom.: 3596 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
32248
AN:
151962
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.226 AC: 55693AN: 246608 AF XY: 0.228 show subpopulations
GnomAD2 exomes
AF:
AC:
55693
AN:
246608
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.232 AC: 335677AN: 1446134Hom.: 39402 Cov.: 29 AF XY: 0.232 AC XY: 167115AN XY: 720132 show subpopulations
GnomAD4 exome
AF:
AC:
335677
AN:
1446134
Hom.:
Cov.:
29
AF XY:
AC XY:
167115
AN XY:
720132
show subpopulations
African (AFR)
AF:
AC:
4654
AN:
33138
American (AMR)
AF:
AC:
8755
AN:
44460
Ashkenazi Jewish (ASJ)
AF:
AC:
5922
AN:
26016
East Asian (EAS)
AF:
AC:
8872
AN:
39558
South Asian (SAS)
AF:
AC:
18927
AN:
85578
European-Finnish (FIN)
AF:
AC:
13520
AN:
53238
Middle Eastern (MID)
AF:
AC:
1033
AN:
5746
European-Non Finnish (NFE)
AF:
AC:
259814
AN:
1098512
Other (OTH)
AF:
AC:
14180
AN:
59888
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
14345
28690
43034
57379
71724
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
8800
17600
26400
35200
44000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.212 AC: 32300AN: 152080Hom.: 3606 Cov.: 33 AF XY: 0.213 AC XY: 15814AN XY: 74328 show subpopulations
GnomAD4 genome
AF:
AC:
32300
AN:
152080
Hom.:
Cov.:
33
AF XY:
AC XY:
15814
AN XY:
74328
show subpopulations
African (AFR)
AF:
AC:
5977
AN:
41480
American (AMR)
AF:
AC:
3435
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
783
AN:
3470
East Asian (EAS)
AF:
AC:
1332
AN:
5160
South Asian (SAS)
AF:
AC:
1067
AN:
4818
European-Finnish (FIN)
AF:
AC:
2675
AN:
10576
Middle Eastern (MID)
AF:
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
AC:
16232
AN:
67984
Other (OTH)
AF:
AC:
508
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1304
2608
3911
5215
6519
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
352
704
1056
1408
1760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1016
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.